Hydrus Microstent
Payments companies reported to CMS as associated with Hydrus Microstent. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Hydrus Microstent, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Hydrus Microstent
These are the largest totals companies reported as associated with Hydrus Microstent. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Nathan Radcliffe | New York, NY | Ophthalmology | $138,876.04 |
| Arsham Sheybani | Saint Louis, MO | Glaucoma Specialist | $105,976.16 |
| Lauren Blieden | Houston, TX | Ophthalmology | $95,831.73 |
| Robert Noecker | Pittsburgh, PA | $85,789.37 | |
| Manjool Shah | Ann Arbor, MI | Ophthalmology | $83,373.02 |
| Inder Singh | Racine, WI | Ophthalmology | $81,927.49 |
| Christine Funke | Phoenix, AZ | Glaucoma Specialist | $79,890.30 |
| Richard Lewis | Sacramento, CA | Ophthalmology | $62,270.17 |
| Roma Patel | Houston, TX | Ophthalmology | $62,036.07 |
| Shamik Bafna | Lafayette, IN | Ophthalmology | $61,471.63 |
Prescribed Hydrus Microstent?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.